Barclays’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90,000
Closed -$3.93M 5323
2025
Q1
$3.93M Buy
+90,000
New +$3.92M ﹤0.01% 2100

Other funds holding DBD

Barclays's DBD Position: Q2 2026 in Review

Barclays increased its Diebold Nixdorf (DBD) stake by 0.77% in Q2 2026, buying an estimated $4.5K and bringing the position to 7,350 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Barclays first reported a position in DBD in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.34M in Q2 2024. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Barclays held 7,350 shares of Diebold Nixdorf worth $625K as of Q2 2026.
  • Barclays bought 56 Diebold Nixdorf shares in Q2 2026, an estimated $4.5K.
  • Diebold Nixdorf made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3092 holding.
  • Barclays first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 11 quarters since.
  • Barclays's Diebold Nixdorf position peaked at $8.34M in Q2 2024.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.